Immunology

Edited by Neeraja Sankaran K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, A.L. Goldberg, "Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules," Cell, 78:761-71, 1994. (Cited in nearly 70 publications through November 1995) Comments by Kenneth Rock, Dana-Farber Cancer Institute, Boston This paper discusses the biochemistry of the cellular processes that allow the immune system to re

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by Neeraja Sankaran

K.L. Rock, C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, A.L. Goldberg, "Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules," Cell, 78:761-71, 1994. (Cited in nearly 70 publications through November 1995) Comments by Kenneth Rock, Dana-Farber Cancer Institute, Boston

This paper discusses the biochemistry of the cellular processes that allow the immune system to recognize various peptides-pieces of protein-present on the surfaces of different cells.

Kenneth Rock ON THE SURFACE: Dana-Farber Cancer Institute's Kenneth Rock and his colleagues determined how MHC-associated peptides are generated.

One of the main interests of the authors of this paper was to determine how these peptides are generated. "Our hypothesis was that the proteasome-a large, multi-subunit protein complex with protein-degrading activity-is somehow involved in breaking down foreign proteins into pieces which are then transported to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies